Fairley, J.A.; Deans, Z.C.; Treacy, R.J.L.; Grieg, E.; Bungartz, K.; Burton, R.; Hayes, J.; Elkin, S.K.
An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment. J. Mol. Pathol. 2022, 3, 125-139.
https://doi.org/10.3390/jmp3030012
AMA Style
Fairley JA, Deans ZC, Treacy RJL, Grieg E, Bungartz K, Burton R, Hayes J, Elkin SK.
An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment. Journal of Molecular Pathology. 2022; 3(3):125-139.
https://doi.org/10.3390/jmp3030012
Chicago/Turabian Style
Fairley, Jennifer A., Zandra C. Deans, Rebecca J. L. Treacy, Eilidh Grieg, Kathryn Bungartz, Ruth Burton, James Hayes, and Sheryl K. Elkin.
2022. "An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment" Journal of Molecular Pathology 3, no. 3: 125-139.
https://doi.org/10.3390/jmp3030012
APA Style
Fairley, J. A., Deans, Z. C., Treacy, R. J. L., Grieg, E., Bungartz, K., Burton, R., Hayes, J., & Elkin, S. K.
(2022). An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment. Journal of Molecular Pathology, 3(3), 125-139.
https://doi.org/10.3390/jmp3030012